Modifié le 29 août 2022
New study to investigate ianalumab and its mechanism of efficacy in Sjögren's patients
New study to investigate the ianalumab monoclonal antibody and its mechanism of efficacy in Sjögren's patients
Modifié le 29 août 2022
New study to investigate the ianalumab monoclonal antibody and its mechanism of efficacy in Sjögren's patients